These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 28132002

  • 21. Characterization of serum cytokines and circulating microRNAs that are predicted to regulate inflammasome genes in cutaneous leishmaniasis patients.
    Mendonça LSO, Santos JM, Kaneto CM, de Carvalho LD, Lima-Santos J, Augusto DG, Carvalho SMS, Soares-Martins JAP, Silva-Jardim I.
    Exp Parasitol; 2020 Mar; 210():107846. PubMed ID: 32001303
    [Abstract] [Full Text] [Related]

  • 22. Study of association of the rs2275913 IL-17A single nucleotide polymorphism and susceptibility to cutaneous leishmaniasis caused by Leishmania braziliensis.
    Gonçalves de Albuquerque SDC, da Costa Oliveira CN, Vaitkevicius-Antão V, Silva AC, Luna CF, de Lorena VMB, de Paiva-Cavalcanti M.
    Cytokine; 2019 Nov; 123():154784. PubMed ID: 31344596
    [Abstract] [Full Text] [Related]

  • 23. Interferon regulatory factor modulation underlies the bystander suppression of malaria antigen-driven IL-12 and IFN-γ in filaria-malaria co-infection.
    Metenou S, Kovacs M, Dembele B, Coulibaly YI, Klion AD, Nutman TB.
    Eur J Immunol; 2012 Mar; 42(3):641-50. PubMed ID: 22213332
    [Abstract] [Full Text] [Related]

  • 24. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX, Barçante TA, Vilela L, Tafuri WL, Afonso LC, Vieira LQ.
    Immunol Lett; 2006 May 15; 105(1):38-47. PubMed ID: 16466810
    [Abstract] [Full Text] [Related]

  • 25. IFNG +874T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma production.
    Matos GI, Covas Cde J, Bittar Rde C, Gomes-Silva A, Marques F, Maniero VC, Amato VS, Oliveira-Neto MP, Mattos Mda S, Pirmez C, Sampaio EP, Moraes MO, Da-Cruz AM.
    BMC Infect Dis; 2007 Apr 24; 7():33. PubMed ID: 17456233
    [Abstract] [Full Text] [Related]

  • 26. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G.
    Eur J Immunol; 1996 Jul 24; 26(7):1553-9. PubMed ID: 8766560
    [Abstract] [Full Text] [Related]

  • 27. [Immunopathology of American tegumentary leishmaniasis].
    Castés M, Tapia FJ.
    Acta Cient Venez; 1998 Jul 24; 49(1):42-56. PubMed ID: 10205916
    [Abstract] [Full Text] [Related]

  • 28. Protein biomarkers discriminate Leishmania major-infected and non-infected individuals in areas endemic for cutaneous leishmaniasis.
    Kammoun-Rebai W, Naouar I, Libri V, Albert M, Louzir H, Meddeb-Garnaoui A, Duffy D.
    BMC Infect Dis; 2016 Mar 24; 16():138. PubMed ID: 27009263
    [Abstract] [Full Text] [Related]

  • 29. Atypical Manifestations of Cutaneous Leishmaniasis in a Region Endemic for Leishmania braziliensis: Clinical, Immunological and Parasitological Aspects.
    Guimarães LH, Queiroz A, Silva JA, Silva SC, Magalhães V, Lago EL, Machado PR, Bacellar O, Wilson ME, Beverley SM, Carvalho EM, Schriefer A.
    PLoS Negl Trop Dis; 2016 Dec 24; 10(12):e0005100. PubMed ID: 27906988
    [Abstract] [Full Text] [Related]

  • 30. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL, Dutra WO, Martins FA, Gontijo B, Carvalho E, Barral-Netto M, Barral A, Almeida RP, Mayrink W, Locksley R, Gollob KJ.
    Infect Immun; 2001 May 24; 69(5):3232-9. PubMed ID: 11292745
    [Abstract] [Full Text] [Related]

  • 31. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
    Tillack C, Ehmann LM, Friedrich M, Laubender RP, Papay P, Vogelsang H, Stallhofer J, Beigel F, Bedynek A, Wetzke M, Maier H, Koburger M, Wagner J, Glas J, Diegelmann J, Koglin S, Dombrowski Y, Schauber J, Wollenberg A, Brand S.
    Gut; 2014 Apr 24; 63(4):567-77. PubMed ID: 23468464
    [Abstract] [Full Text] [Related]

  • 32. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
    Khalil EA, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM.
    Clin Exp Immunol; 2005 May 24; 140(2):349-53. PubMed ID: 15807861
    [Abstract] [Full Text] [Related]

  • 33. Effects of Pregnancy-associated Malaria on T Cell Cytokines in Cameroonian Women.
    Megnekou R, Lissom A, Bigoga JD, Djontu JC.
    Scand J Immunol; 2015 Jun 24; 81(6):508-14. PubMed ID: 25736985
    [Abstract] [Full Text] [Related]

  • 34. American tegumentary leishmaniasis: mRNA expression for Th1 and Treg mediators are predominant in patients with recent active disease.
    Souza MA, Almeida TM, Castro MC, Oliveira-Mendes AP, Almeida AF, Oliveira BC, Rocha LF, Medeiros AC, Brito ME, Dessein AJ, Pereira VR.
    Immunobiology; 2016 Feb 24; 221(2):253-9. PubMed ID: 26572279
    [Abstract] [Full Text] [Related]

  • 35. Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials.
    Maurer-Cecchini A, Decuypere S, Chappuis F, Alexandrenne C, De Doncker S, Boelaert M, Dujardin JC, Loutan L, Dayer JM, Tulliano G, Arevalo J, Llanos-Cuentas A, Chizzolini C.
    Infect Immun; 2009 May 24; 77(5):2022-9. PubMed ID: 19237520
    [Abstract] [Full Text] [Related]

  • 36. Gene expression profile of cytokines produced in biopsies from patients with American cutaneous leishmaniasis.
    Hippólito DDC, Gomes AHS, Maia MM, Meira-Strejevitch CDS, Kanamura CT, Lauletta Lindoso JA, Pereira-Chioccola VL.
    Acta Trop; 2019 Jan 24; 189():69-75. PubMed ID: 30273562
    [Abstract] [Full Text] [Related]

  • 37. Cutaneous leishmaniasis in naturally infected dogs is associated with a T helper-2-biased immune response.
    Brachelente C, Müller N, Doherr MG, Sattler U, Welle M.
    Vet Pathol; 2005 Mar 24; 42(2):166-75. PubMed ID: 15753470
    [Abstract] [Full Text] [Related]

  • 38. Gene expression profile of cytokines and chemokines in skin lesions from Brazilian Indians with localized cutaneous leishmaniasis.
    Costa-Silva MF, Gomes LI, Martins-Filho OA, Rodrigues-Silva R, Freire Jde M, Quaresma PF, Pascoal-Xavier MA, Mendes TA, Serakides R, Zauli DA, Campi-Azevedo AC, Melo MN, Gontijo CM, Peruhype-Magalhães V, Teixeira-Carvalho A.
    Mol Immunol; 2014 Feb 24; 57(2):74-85. PubMed ID: 24084096
    [Abstract] [Full Text] [Related]

  • 39. Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis.
    Ajdary S, Riazi-Rad F, Alimohammadian MH, Pakzad SR.
    J Infect; 2009 Aug 24; 59(2):139-43. PubMed ID: 19560211
    [Abstract] [Full Text] [Related]

  • 40. Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12.
    Bourreau E, Prévot G, Pradinaud R, Launois P.
    J Infect Dis; 2001 Mar 15; 183(6):953-9. PubMed ID: 11237813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.